From Fin Revue today J P Morgan Down from a buy to underperform Hard to place a value yardstick on the stock other than its cash backing Silex has $35mill on its balance sheet representing 30c a share
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution